Philippe Hantraye

18.3k total citations · 1 hit paper
199 papers, 12.5k citations indexed

About

Philippe Hantraye is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Philippe Hantraye has authored 199 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Cellular and Molecular Neuroscience, 77 papers in Molecular Biology and 67 papers in Neurology. Recurrent topics in Philippe Hantraye's work include Genetic Neurodegenerative Diseases (61 papers), Neurological disorders and treatments (54 papers) and Neuroscience and Neuropharmacology Research (48 papers). Philippe Hantraye is often cited by papers focused on Genetic Neurodegenerative Diseases (61 papers), Neurological disorders and treatments (54 papers) and Neuroscience and Neuropharmacology Research (48 papers). Philippe Hantraye collaborates with scholars based in France, United States and Switzerland. Philippe Hantraye's co-authors include Emmanuel Brouillet, Nicole Déglon, Stéphane Palfi, M. Mazière, Philippe Rémy, Marc Peschanski, Gilles Bonvento, D. Riché, Gwennaëlle Aurégan and Noëlle Dufour and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Philippe Hantraye

196 papers receiving 12.3k citations

Hit Papers

Neurodegeneration Prevented by Lentiviral Vector Delivery... 2000 2026 2008 2017 2000 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Hantraye France 61 7.0k 5.7k 3.7k 1.7k 1.4k 199 12.5k
Erlend A. Nagelhus Norway 39 5.8k 0.8× 4.4k 0.8× 2.7k 0.7× 1.4k 0.9× 2.3k 1.6× 74 11.8k
Mathias Bähr Germany 76 5.9k 0.8× 9.2k 1.6× 2.5k 0.7× 1.7k 1.0× 2.8k 1.9× 356 17.3k
Emmanuel Brouillet France 57 6.6k 0.9× 6.0k 1.0× 3.0k 0.8× 1.5k 0.9× 1.1k 0.7× 156 10.5k
Stefan Schulz Germany 66 5.2k 0.7× 6.5k 1.1× 1.3k 0.4× 1.8k 1.0× 569 0.4× 273 13.7k
Blair R. Leavitt Canada 70 14.4k 2.1× 13.5k 2.4× 7.5k 2.0× 1.4k 0.8× 1.4k 1.0× 230 20.9k
Wen‐Cheng Xiong United States 72 5.1k 0.7× 9.7k 1.7× 1.6k 0.4× 1.7k 1.0× 908 0.6× 241 15.9k
Tsutomu Hashikawa Japan 56 4.0k 0.6× 4.0k 0.7× 2.2k 0.6× 1.3k 0.8× 1.5k 1.0× 163 10.6k
Giuseppe Battaglia Italy 63 7.8k 1.1× 4.9k 0.8× 1.9k 0.5× 1.8k 1.1× 1.7k 1.2× 325 13.3k
Thomas Deller Germany 59 5.9k 0.8× 4.0k 0.7× 1.6k 0.4× 2.5k 1.5× 2.5k 1.7× 228 11.0k
Dietmar Kuhl Germany 62 4.9k 0.7× 7.8k 1.4× 1.5k 0.4× 1.8k 1.1× 917 0.6× 169 18.2k

Countries citing papers authored by Philippe Hantraye

Since Specialization
Citations

This map shows the geographic impact of Philippe Hantraye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Hantraye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Hantraye more than expected).

Fields of papers citing papers by Philippe Hantraye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Hantraye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Hantraye. The network helps show where Philippe Hantraye may publish in the future.

Co-authorship network of co-authors of Philippe Hantraye

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Hantraye. A scholar is included among the top collaborators of Philippe Hantraye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Hantraye. Philippe Hantraye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Badin, Romina Aron, et al.. (2024). Viral-based animal models in polyglutamine disorders. Brain. 147(4). 1166–1189. 2 indexed citations
2.
Fenyi, Alexis, Sonia Lavisse, Sandra Doveró, et al.. (2023). Functional and neuropathological changes induced by injection of distinct alpha-synuclein strains: A pilot study in non-human primates. Neurobiology of Disease. 180. 106086–106086. 11 indexed citations
3.
Mangin, Jean‐François, Denis Rivière, Édouard Duchesnay, et al.. (2020). Neocortical morphometry in Huntington's disease: Indication of the coexistence of abnormal neurodevelopmental and neurodegenerative processes. NeuroImage Clinical. 26. 102211–102211. 19 indexed citations
4.
Badin, Romina Aron, Katie Binley, Nadja Van Camp, et al.. (2019). Gene Therapy for Parkinson’s Disease: Preclinical Evaluation of Optimally Configured TH:CH1 Fusion for Maximal Dopamine Synthesis. Molecular Therapy — Methods & Clinical Development. 14. 206–216. 19 indexed citations
5.
Palfi, Stéphane, H. Lepetit, G. Ralph, et al.. (2018). Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease. PubMed. 29(3). 148–155. 105 indexed citations
6.
Senova, Sühan, Cyril Poupon, Julien Dauguet, et al.. (2018). Optogenetic Tractography for anatomo-functional characterization of cortico-subcortical neural circuits in non-human primates. Scientific Reports. 8(1). 3362–3362. 14 indexed citations
7.
Balbastre, Yaël, Denis Rivière, Clara Fischer, et al.. (2017). A validation dataset for Macaque brain MRI segmentation. Data in Brief. 16. 37–42. 3 indexed citations
8.
Damiano, Maria, Elsa Diguet, Carole Malgorn, et al.. (2013). A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Human Molecular Genetics. 22(19). 3869–3882. 89 indexed citations
9.
Badin, Romina Aron, B. Spinnewyn, Marie‐Claude Gaillard, et al.. (2013). Correction: IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates. PLoS ONE. 8(1). 1 indexed citations
10.
Caillierez, Raphaëlle, Séverine Bégard, Katia Lécolle, et al.. (2013). Lentiviral Delivery of the Human Wild-type Tau Protein Mediates a Slow and Progressive Neurodegenerative Tau Pathology in the Rat Brain. Molecular Therapy. 21(7). 1358–1368. 26 indexed citations
11.
Faideau, Mathilde, Jae-Hwan Kim, Kerry Cormier, et al.. (2010). In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects. Human Molecular Genetics. 19(15). 3053–3067. 250 indexed citations
12.
Benchoua, Alexandra, Yaël Trioulier, Elsa Diguet, et al.. (2008). Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II. Human Molecular Genetics. 17(10). 1446–1456. 54 indexed citations
13.
Escartin, Carole, Karin Pierre, Emmanuel Brouillet, et al.. (2007). Activation of Astrocytes by CNTF Induces Metabolic Plasticity and Increases Resistance to Metabolic Insults. Journal of Neuroscience. 27(27). 7094–7104. 104 indexed citations
14.
Escartin, Carole, Emmanuel Brouillet, Paolo Gubellini, et al.. (2006). Ciliary Neurotrophic Factor Activates Astrocytes, Redistributes Their Glutamate Transporters GLAST and GLT-1 to Raft Microdomains, and Improves Glutamate HandlingIn Vivo. Journal of Neuroscience. 26(22). 5978–5989. 75 indexed citations
15.
Vaufrey, Françoise, Françoise Condé, Fabrice Chrétien, et al.. (2004). Up‐regulation of glutamate concentration in the putamen and in the prefrontal cortex of asymptomatic SIVmac251‐infected macaques without major brain involvement. Journal of Neurochemistry. 88(4). 928–938. 14 indexed citations
16.
Bizat, Nicolas, Jean‐Michel Hermel, Frédéric Boyer, et al.. (2003). Calpain Is a Major Cell Death Effector in Selective Striatal Degeneration InducedIn Vivoby 3-Nitropropionate: Implications for Huntington's Disease. Journal of Neuroscience. 23(12). 5020–5030. 145 indexed citations
17.
Chaldée, Michel de, Marie‐Claude Gaillard, Nicolas Bizat, et al.. (2003). Quantitative Assessment of Transcriptome Differences Between Brain Territories. Genome Research. 13(7). 1646–1653. 26 indexed citations
18.
Ribeiro, Maria-João, Marie Vidailhet, Christian Loc’h, et al.. (2002). Dopaminergic Function and Dopamine Transporter Binding Assessed With Positron Emission Tomography in Parkinson Disease. Archives of Neurology. 59(4). 580–580. 105 indexed citations
19.
Ouary, Stéphane, Nicolas Bizat, Vincent Mittoux, et al.. (2000). Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies. Neuroscience. 97(3). 521–530. 91 indexed citations
20.
Palfi, Stéphane, D. Riché, Emmanuel Brouillet, et al.. (1997). Riluzole Reduces Incidence of Abnormal Movements but Not Striatal Cell Death in a Primate Model of Progressive Striatal Degeneration. Experimental Neurology. 146(1). 135–141. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026